GO:1990452 Parkin-FBXW7-Cul1 ubiquitin ligase complex

GO:1990452, the Parkin-FBXW7-Cul1 ubiquitin ligase complex, is a cellular component defined in QuickGO as a ubiquitin ligase complex containing Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10), and a cullin from the Cul1 subfamily, with substrate specificity conferred by the F-box protein. This complex represents a specialized assembly within the broader family of cullin-RING ubiquitin ligases, which are central to regulated protein degradation in eukaryotic cells. Because the F-box protein dictates which substrates are recognized, the identity of FBXW7 within this complex directly determines its downstream biological impact. For researchers, GO:1990452 matters because it connects three proteins with well-documented roles in human disease: Parkin (PARK2), FBXW7, and Cul1-subfamily cullins. Parkin is widely studied in neurodegeneration, while FBXW7 is a well-known tumor suppressor implicated in multiple cancers. The convergence of these proteins into a single ubiquitin ligase complex suggests that their functions may be coordinated rather than independent, offering a richer framework for experimental design. Recent work has begun to link components of this complex to specific disease contexts, including Wilms tumor, where lipid metabolism gene regulation and miRNA-associated networks have been investigated. Such findings underscore the value of studying GO:1990452 not only as a structural annotation but as a functional node in disease-relevant regulatory networks. This article reviews the definition, composition, mechanism, disease links, and research methods relevant to GO:1990452, based strictly on the QuickGO definition and verified published literature.

In simple terms, GO:1990452 is a tag for a specific protein machine that attaches ubiquitin molecules to other proteins, marking them for degradation or altered function. According to QuickGO, this machine contains three key parts: Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10), and a cullin from the Cul1 subfamily. The F-box protein, FBXW7, is the component that decides which target proteins the complex will act on, thereby conferring substrate specificity. The complex is classified as a cellular component, meaning it is a physical structure within the cell rather than a process or a molecular activity on its own.

GO:1990452 is important because it defines a specific ubiquitin ligase assembly that links three proteins with major disease relevance: Parkin (PARK2), FBXW7, and Cul1-subfamily cullins. Ubiquitin ligases control the stability of many regulatory proteins, and the F-box protein within the complex determines which substrates are targeted. By studying this complex, researchers can better understand how protein degradation is directed in cancer and other disease contexts, including Wilms tumor where lipid metabolism gene networks have been associated with miRNA regulation.

The following genes and proteins are directly or functionally associated with GO:1990452 and its broader ubiquitin ligase biology, based on the QuickGO definition and verified literature.

Regulation of the Parkin-FBXW7-Cul1 ubiquitin ligase complex is not fully detailed in the QuickGO definition, but its activity is expected to depend on the availability and assembly of its core components: Parkin, FBXW7, and a Cul1-subfamily cullin. Because substrate specificity is conferred by the F-box protein FBXW7, changes in FBXW7 expression or function would directly alter the complex's targeting preferences. Additionally, miRNA-mediated regulation of lipid metabolism genes, such as FASN, has been investigated in Wilms tumor, suggesting that non-coding RNA networks may influence related ubiquitination pathways. Further experimental work is needed to define the precise regulatory inputs controlling this complex.

Components linked to GO:1990452, particularly FBXW7, are associated with cancer biology. Recent studies have identified and validated lipid metabolism gene FASN-associated miRNA in Wilms tumor, highlighting a potential connection between ubiquitin ligase-related pathways and metabolic gene regulation in pediatric renal tumors. The Parkin-FBXW7-Cul1 complex may influence cancer-relevant protein turnover, although direct evidence in Wilms tumor requires further investigation.

Parkin (PARK2) is a core component of GO:1990452 and is widely studied in neurodegeneration. The inclusion of Parkin in this ubiquitin ligase complex suggests that it may contribute to protein quality control pathways relevant to neuronal health. However, the specific role of the Parkin-FBXW7-Cul1 complex in neurodegenerative disease remains an active area of research.

The study of FASN-associated miRNA in Wilms tumor indicates that lipid metabolism genes can be regulated by non-coding RNAs in disease contexts. This raises the possibility that the Parkin-FBXW7-Cul1 complex, through its ubiquitination activity, may intersect with metabolic regulatory networks. Further work is needed to establish direct mechanistic links.

Proteomic approaches such as immunoprecipitation coupled to mass spectrometry can be used to isolate the Parkin-FBXW7-Cul1 complex and identify its interacting partners and substrates. Tagged knock-in of core components, such as CUL1 or FBXW7, facilitates affinity purification. These methods help define the composition and dynamics of GO:1990452 in cells.

RNA sequencing and miRNA profiling can reveal how components of the Parkin-FBXW7-Cul1 complex influence gene expression networks. In Wilms tumor, lipid metabolism gene FASN-associated miRNA has been identified and validated, demonstrating the utility of transcriptomic approaches in disease contexts. Such studies can uncover regulatory links between ubiquitin ligases and metabolic pathways.

CRISPR knockout and point-mutation screens enable systematic interrogation of genes encoding Parkin, FBXW7, and Cul1-subfamily cullins. These screens can identify which substrates and pathways depend on the complex. Functional readouts may include cell proliferation, protein stability, and metabolic assays.

Fluorescence imaging of tagged complex components can reveal where the Parkin-FBXW7-Cul1 complex localizes within cells. Co-localization with proteasome markers or substrate proteins can provide insight into its function. Live-cell imaging may capture dynamic assembly and disassembly events.

Researchers studying Parkin-FBXW7-Cul1 ubiquitin ligase complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, substrate recognition, or downstream disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with rigor and reproducibility.

GO:1990452, the Parkin-FBXW7-Cul1 ubiquitin ligase complex, is a defined cellular component that brings together Parkin, FBXW7, and a Cul1-subfamily cullin to regulate protein ubiquitination with substrate specificity determined by the F-box protein. Its components are linked to cancer biology, including Wilms tumor, and to neurodegeneration through Parkin. Studying this complex with CRISPR-based models and omics approaches will continue to clarify its roles in health and disease.